EUTOS for CML

EUTOS for CML is a unique collaboration between the European LeukemiaNet and Novartis Oncology in Europe

News

2008/10/23:
Download Materials: Flyer, Poster, Exhibition Booth

2008/07/08:
Update of the Spread of Excellence activities, July 2008

Events
Th 2009/06/04 - Tu 2009/07/07 EHA 2009 14th Congress of the EHA
Th 2010/06/10 - Su 2010/06/13 EHA 2010: 15th Congress of the EHA

The EUropean Treatment Outcome Study (EUTOS) is a collaboration between the European LeukemiaNet ELN and Novartis to improve understanding of CML, promote best practise, and enhance treatment outcomes, through 4 key projects:

CML registry
Molecular monitoring
Pharmacologic monitoring
Spread of excellence.

Major aims of the alliance are, to:

Enhance understanding of the nature and management of CML
Improve standardized evaluation and monitoring of treatments for CML
Optimize treatment of CML patients across Europe

Created by: A. Hellenbrecht , generated 2007/12/19 , last changed: 2008/07/23

European LeukemiaNet